Biodiem share price
WebMar 29, 2024 · Griffith University’s Industry Fund collaborates in BDM-I screening. April. 30/04/2014. Completion of Non-renounceable Entitlement Offer and Issue of Entitlement and Shortfall Shares. BDM-I antimicrobial – mechanism of action investigation. 23/04/2014. Non-Renounceable Entitlement Offer – Closure, Acceptances and Shortfall. 10/04/2014. WebBiodiem Def share price and BDMN stock charts. Free real-time prices and the UK's most active stock market forums. Biodiem Def (BDMN) share price, charts, trades & the UK's …
Biodiem share price
Did you know?
http://www.biodiem.com/share-trading/ WebBioDiem Summary. Company summary. Overview. BioDiem is a biopharmaceutical company focused on developing and commercializing vaccines and infectious disease therapies. It offers LAIV (Live Attenuated Influenza Virus) vaccine technology that is used for the production of seasonal and pandemic influenza vaccines and is given intranasally.
WebJan 29, 2004 · Investors in drug development company BioDiem were disappointed yesterday as its share price slid after its debut on the Australian Stock Exchange. WebAug 7, 2012 · Published: Aug 07, 2012. Melbourne, 8 August 2012: Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, …
WebFinal gross price and currency may vary according to local VAT and billing address. ... (Biodiem website, December 2024) 29 Dec 2024 Preclinical trials in Bacterial infections in USA (unspecified route) (Biodiem website, December 2024) Subscriber content You need to be a logged in subscriber to view this content. ... WebCompany profile page for Biodiem Ltd including stock price, company news, press releases, executives, board members, and contact information
WebLegal Name BioDiem Ltd. Company Type For Profit. Contact Email [email protected]. Phone Number + 61 3 9692 7240. BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Their business model is to generate income from partnerships including with …
WebBIODIEM LTD ABN 20 096 845 993 Level 4, 100 Albert Road, South Melbourne, Victoria, 3205 Australia Phone: +613 9692 7240 Web: www.biodiem.com ... The EOFY 2024 share price information is as follows:, being the last sale price: • BioDiem ordinary shares = … howard productionsWebBDM BIODIEM FPO Basic Materials. Diamonds Gold Silver. $0.300 (0%) High-Low-Trades-Turnover. $0: Volume. 0: 13 April 2024 at 8:20pm Track Stock ... Price Sensitive News … howard proctor artisthttp://www.biodiem.com/ howard production soundWebFeb 2, 2024 · BIODIEM LTD. (ASX:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BIODIEM LTD. Australian Stock Exchange: Australian … how many kids does israel houghton haveWebOct 18, 2012 · Melbourne, 18 October 2012: Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today that it continues to make solid progress on its antimicrobial program with advancing preclinical data, new partnerships in negotiation, and a number of new key patents strengthening BioDiem’s … how many kids does india royaleWebJul 12, 2010 · Published: Jul 12, 2010. Melbourne, Monday 12 July 2010: (ASX: BDM) BioDiem Ltd’s lead product, the Live Attenuated Influenza Vaccine (LAIV) has been granted regulatory approval for marketing in India. “NasoVac” was launched this week by the Indian vaccine company, the Serum Institute of India (“SII”). This is the first approval for ... how many kids does jackie rivera havehttp://www.biodiem.com/announcements/ how many kids does jack abbott have on the yr